Webinar - Your Faster Biologics Path: Smarter Screening, Flexible Cell Line Development, and 4-Month ExpressCMC™

sdAbs are unique type of antibodies derived from camelids and widely used as therapeutics, especially as building blocks for multi-specific antibodies. Our first session will explore phage display and single B-cell technologies for sdAb lead generation, comparing their key features.

To accelerate CMC development, ProBio introduced ExpressCMC™—achieving an industry-leading 4-month timeline from DNA to tox batch using an innovative cell line platform. The second session will reveal how we make this possible for your process.

• 

  Derek Chen
  Sr. Director, Antibody Drug Discovery Dept., ProBio

• 

  Ying Li
  Director of Antibody PD Dept., ProBio

Related service: Cell line development, ADCC Enhanced Cell Line Development, IND-enabling CMC

Available materials